Differential Intervention Trial by Standard Therapy Versus Pitavastatin in Patients With Chronic Hemodialysis (DIALYSIS)

• Status: Terminated
• Trial end date: 2014-09-30
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to verify whether pitavastatin prevents from cardiovascular events and improves the mortality in chronic hemodialysis patients with hypercholesteremia.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chieko Hamada
• Treatments: Pitavastatin

Criteria

Inclusion Criteria:

• patients under hemodialysis

• patients with hypercholesterolemia as defined by any of following parameters:

• LDL-C ≧ 100 mg / dL

• TC ≧ 180 mg / dL

• patients required cholesterol-lowering treatment by investigators.

• patients aged 20-75 years

• patients with written consent by their own volition after being provided sufficient explanation for the participation into this clinical trial

Exclusion Criteria:

• patients taking statins or fibrates

• patients enrolled to the other trials using contraindication drugs of pitavastatin

• patients who had acute myocardial infarction within six months before the day of the agreement acquisition

• patients scheduled PCI and CABG within six months after the day of the agreement acquisition

• Patients who had diagnosis or doubt of malignant tumor

• patients corresponded to "Contraindications" of pitavastatin

• Familial hypercholesterolemia patients

• patients judged ineligible by investigators